Invesco’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
26,866
+2,556
| +11% | +$111K | ﹤0.01% | 2782 |
|
|
2025
Q1 | $908K | Buy |
24,310
+3,054
| +14% | +$114K | ﹤0.01% | 2867 |
|
|
2024
Q4 | $963K | Sell |
21,256
-110,910
| -84% | -$5.02M | ﹤0.01% | 2925 |
|
|
2024
Q3 | $7.76M | Buy |
132,166
+111,783
| +548% | +$6.57M | ﹤0.01% | 1972 |
|
|
2024
Q2 | $802K | Sell |
20,383
-96,290
| -83% | -$3.79M | ﹤0.01% | 3040 |
|
|
2024
Q1 | $7.75M | Buy |
116,673
+105,064
| +905% | +$6.98M | ﹤0.01% | 1960 |
|
|
2023
Q4 | $324K | Buy |
11,609
+1,917
| +20% | +$53.6K | ﹤0.01% | 3397 |
|
|
2023
Q3 | $206K | Buy |
+9,692
| New | +$206K | ﹤0.01% | 3567 |
|